With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, Complex 2 was obtained by a similar method as described for 1 using copper(I) bromide (0.032 g,0.22 mmol) in place of copper(I) iodide. Colorless crystals of 2 were obtained (Yield: 0.191 g, 90.3%). 1HNMR (400 M, CDCl3) delta: 7.51-7.36 (m, 22H, m,p-Ph + H3,H4-PC6H4-), 7.33-7.27 (m, 4H, H5,H6-PC6H4-),7.12-7.00 (m, 12H, o-Ph). 13C NMR (100 M, CDCl3) delta: 147.87, 147.67, 140.24, 140.16, 134.31, 134.17, 133.45,131.80, 131.07, 130.71, 130.14, 129.90, 128.93, 128.69, 127.93, 127.26 (Ar-C). 31P NMR (240 M, CDCl3) delta:-9.70 (s). Anal. Calcd for C48H38Cu2Br2P2: C, 59.83; H, 3.97. Found: C, 59.88; H, 3.97. MS (MALDI-TOF): m/zCalcd for [M-2Br-Cu + C24H19P]+, 739.1745, found 739.1747.
The synthetic route of 7787-70-4 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Qi, Lei; Li, Qian; Hong, Xiao; Liu, Li; Zhong, Xin-Xin; Chen, Qiao; Li, Fa-Bao; Liu, Qian; Qin, Hai-Mei; Wong, Wai-Yeung; Journal of Coordination Chemistry; vol. 69; 24; (2016); p. 3692 – 3702;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”